Aptus Capital Advisors’s Invesco Pharmaceuticals ETF PJP Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $16.3K | Buy |
204
+1
| +0.5% | +$80 | ﹤0.01% | 1306 |
|
|
2025
Q1 | $17.6K | Buy |
203
+1
| +0.5% | +$87 | ﹤0.01% | 1224 |
|
|
2024
Q4 | $16.7K | Hold |
202
| – | – | ﹤0.01% | 1229 |
|
|
2024
Q3 | $17.6K | Buy |
202
+1
| +0.5% | +$87 | ﹤0.01% | 1052 |
|
|
2024
Q2 | $16.5K | Hold |
201
| – | – | ﹤0.01% | 989 |
|
|
2024
Q1 | $16.1K | Buy |
201
+1
| +0.5% | +$80 | ﹤0.01% | 988 |
|
|
2023
Q4 | $15.2K | Buy |
200
+25
| +14% | +$1.9K | ﹤0.01% | 766 |
|
|
2023
Q3 | $12.7K | Hold |
175
| – | – | ﹤0.01% | 781 |
|
|
2023
Q2 | $13.2K | Buy |
+175
| New | +$13.2K | ﹤0.01% | 667 |
|
|
2023
Q1 | – | Sell |
-175
| Closed | -$13.8K | – | 861 |
|
|
2022
Q4 | $13.8K | Hold |
175
| – | – | ﹤0.01% | 673 |
|
|
2022
Q3 | $12K | Buy |
+175
| New | +$12K | ﹤0.01% | 644 |
|